• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrroles Pyrrole carboxylic acids and derivatives

Recent Advances in the Application of Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate (CAS: 5408-07-1) in Chemical Biology and Pharmaceutical Research

Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate (CAS: 5408-07-1) is a brominated pyrrole derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including potential drug candidates. Recent studies have explored its utility in medicinal chemistry, particularly in the development of novel therapeutic agents targeting infectious diseases, cancer, and inflammatory disorders.

One of the most notable advancements involving Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate is its role in the synthesis of pyrrole-based scaffolds for drug discovery. Researchers have utilized this compound to develop inhibitors of specific enzymes and receptors, such as kinase inhibitors and G-protein-coupled receptor (GPCR) modulators. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's efficacy in the synthesis of selective kinase inhibitors with potential applications in oncology. The study highlighted the compound's ability to introduce bromine at the 4-position, which is critical for enhancing binding affinity and selectivity.

In addition to its role in drug discovery, Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate has been investigated for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) reported that derivatives of this compound exhibited potent activity against multidrug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The researchers attributed this activity to the bromine substituent, which enhances the compound's interaction with bacterial cell membranes and intracellular targets.

Another emerging application of Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate is in the field of chemical biology, where it is used as a building block for the development of fluorescent probes and imaging agents. A 2024 study in Chemical Communications described the synthesis of a pyrrole-based fluorescent probe derived from this compound, which was used to visualize reactive oxygen species (ROS) in live cells. This innovation opens new avenues for studying oxidative stress-related diseases, such as neurodegenerative disorders and cancer.

Despite its promising applications, challenges remain in the large-scale synthesis and optimization of Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate derivatives. Recent efforts have focused on improving synthetic methodologies to enhance yield and purity. For example, a 2023 publication in Organic Process Research & Development outlined a scalable and environmentally friendly synthesis route for this compound, utilizing catalytic bromination and esterification techniques.

In conclusion, Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate (CAS: 5408-07-1) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its biological activity, makes it a compound of significant interest for future studies. Ongoing research is expected to further elucidate its potential in drug development and diagnostic applications, paving the way for innovative therapeutic solutions.

• 89909-49-9(1H-Pyrrole-3-acetic acid, 4-bromo-2-(ethoxycarbonyl)-5-methyl-, ethyl ester)
• 89909-39-7(1H-Pyrrole-2-carboxylic acid, 4-bromo-5-methyl-, phenylmethyl ester)
• 861034-50-6(ethyl 3-bromo-4-cyano-5-methyl-1H-pyrrole-2-carboxylate)
• 213771-32-5(methyl 5-bromo-3-methylpyridine-2-carboxylate)
• 1092286-06-0(4-Bromo-3-methyl-1H-pyrrole-2-carboxylic acid)
• 1266378-71-5(methyl 4-bromo-3-methyl-pyridine-2-carboxylate)
• 89909-42-2(1H-Pyrrole-2-carboxylicacid, 4-bromo-3-methyl-, ethyl ester)
• 794592-13-5(5-Bromo-3-Methylpyridine-2-Carboxylic Acid Ethyl Ester)
• 1122090-39-4(Ethyl 5-bromo-4-methylpicolinate)
• 25907-29-3(Ethyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate)